Crecen esperanzas sobre vacuna de Oxford mientras la OMS dice que ‘el virus aún no está cansado de nosotros’

Aún con la alternativa de Pfizer y de Sputnik en Rusia, la vacuna de Oxford pretender ser más fácil en su implementación.

'Anti-vaxx is total nonsense': Johnson urges eligible Brits to take Covid vaccine
Read in English

La vacuna de Oxford aún podría ser pionera en la lucha contra la pandemia de coronavirus en el Reino Unido, ya que se espera que sea más fácil de almacenar y distribuir que la vacuna de Pfizer .

Si bien el gigante farmacéutico Pfizer, en colaboración con la empresa de biotecnología alemana BioNTech, anunció que las pruebas iniciales sugerían que su vacuna tenía una efectividad superior al 90 por ciento, se han planteado preocupaciones sobre la logística de la distribución del jab.

La vacuna debe mantenerse a -70 ° C hasta el día en que se use para mantener la integridad del material genético de las dosis, algo que muchas clínicas de médicos de cabecera y residencias de ancianos no podrán hacer.

Debido a esto, se espera que la vacuna de la Universidad de Oxford, que puede almacenarse entre 2C y 8C, sea más fácil de administrar en la comunidad y, por lo tanto, proporcione la base del programa de vacunación del Reino Unido.

Tedros Adhanom Ghebreyesus, director general de la Organización Mundial de la Salud (OMS), advirtió al público que “puede que esté cansado del Covid-19 , pero no está cansado de nosotros” e instó a la gente a permanecer en alerta máxima. El Dr. Ghebreyesus dijo que el virus "no ha cambiado significativamente, ni las medidas para detenerlo".

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in